Patrick Mallon

InstitutionUniversity College Dublin
AddressDublin
Ireland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 15 Covid-19 publications, with a maximum of 2 publications in December 2020 and March 2021
    All Publications
    Bar chart showing 77 publications over 19 distinct years, with a maximum of 9 publications in 2016 and 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O'Sullivan JM, Martin-Loeches I, Nadarajan P, Bannan C, Mallon PW, Curley GF, Preston RJS, Rehill AM, McGonagle D, Ni Cheallaigh C, Baker RI, Renné T, Ward SE, O'Donnell JS. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021 10; 19(10):2546-2553. PMID: 34375505.
      Citations: 10     Fields:    Translation:Humans
    2. Kenny G, Mallon PWG. Tocilizumab for the treatment of non-critical COVID-19 pneumonia: an overview of the rationale and clinical evidence to date. Expert Rev Clin Pharmacol. 2021 Oct; 14(10):1279-1287. PMID: 34187281.
      Citations: 1     Fields:    Translation:Humans
    3. Ward SE, Fogarty H, Karampini E, Lavin M, Schneppenheim S, Dittmer R, Morrin H, Glavey S, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Mallon PW, Curley GF, Baker RI, Budde U, O'Sullivan JM, O'Donnell JS. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19. J Thromb Haemost. 2021 08; 19(8):1914-1921. PMID: 34053187.
      Citations: 8     Fields:    Translation:Humans
    4. Mallon PWG, Tinago W, Leon AG, McCann K, Kenny G, McGettrick P, Green S, Inzitari R, Cottere AG, Feeney ER, Savinelli S, Doran P. Dynamic Change and Clinical Relevance of Postinfectious SARS-CoV-2 Antibody Responses. Open Forum Infect Dis. 2021 Aug; 8(8):ofab122. PMID: 34377721.
      Citations:    
    5. O'Morain N, Coe C, Mallon P, Twomey P, De Gascun CF, Doherty GA. Letter: how frequently does COVID-19 mimic an IBD flare when community transmission of SARS-CoV-2 is active? Aliment Pharmacol Ther. 2021 03; 53(5):674-675. PMID: 33566397.
      Citations:    Fields:    Translation:HumansCells
    6. Comer SP, Cullivan S, Szklanna PB, Weiss L, Cullen S, Kelliher S, Smolenski A, Murphy C, Altaie H, Curran J, O'Reilly K, Cotter AG, Marsh B, Gaine S, Mallon P, McCullagh B, Moran N, Ní Áinle F, Kevane B, Maguire PB. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol. 2021 02; 19(2):e3001109. PMID: 33596198.
      Citations: 22     Fields:    Translation:HumansCells
    7. Guaraldi G, Milic J, Martinez E, Kamarulzaman A, Mussini C, Waters L, Pozniak A, Mallon P, Rockstroh J, Lazarus JV. HIV care models during the COVID-19 era. Clin Infect Dis. 2020 Dec 19. PMID: 33340037.
      Citations: 5     Fields:    
    8. Ward SE, Curley GF, Lavin M, Fogarty H, Karampini E, McEvoy NL, Clarke J, Boylan M, Alalqam R, Worrall AP, Kelly C, de Barra E, Glavey S, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Townsend L, Mallon PW, O'Sullivan JM, O'Donnell JS. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. Br J Haematol. 2021 02; 192(4):714-719. PMID: 33326604.
      Citations: 23     Fields:    Translation:HumansCells
    9. Kenny G, Mallon PW. COVID19- clinical presentation and therapeutic considerations. Biochem Biophys Res Commun. 2021 01 29; 538:125-131. PMID: 33218685.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    10. Winston A, De Francesco D, Post F, Boffito M, Vera J, Williams I, Anderson J, Mallon PWG, Sabin CA. Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes. AIDS. 2020 10 01; 34(12):1795-1800. PMID: 32732634.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    11. Cotter A, Wallace D, McCarthy C, Feeney E, O'Neill L, Stack J, McCarthy G, Hussain R, Alvarez Barco E, Doran P, Mallon P. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 03; 21(1):758. PMID: 32883328.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    12. O'Carroll O, MacCann R, O'Reilly A, Dunican EM, Feeney ER, Ryan S, Cotter A, Mallon PW, Keane MP, Butler MW, McCarthy C. Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia. Eur Respir J. 2020 08; 56(2). PMID: 32616588.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    13. McCarthy C, Savinelli S, Feeney ER, Butler MW, O'Broin C, Ryan S, O'Neill L, Murphy DJ, Gallagher CG, McKone EF, Waqas S, Cotter A, Doran P, Keane MP, Mallon PW. Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state. Respirology. 2020 10; 25(10):1090-1094. PMID: 32696570.
      Citations: 6     Fields:    
    14. Butler MW, O'Reilly A, Dunican EM, Mallon P, Feeney ER, Keane MP, McCarthy C. Prevalence of comorbid asthma in COVID-19 patients. J Allergy Clin Immunol. 2020 08; 146(2):334-335. PMID: 32553599.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    15. Feeney E, Wallace D, Cotter A, Tinago W, McCarthy C, Keane D, Hussain R, Alvarez Barco E, Doran P, Mallon P. The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 05 25; 21(1):430. PMID: 32450915.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    Mallon's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (105)
    Explore
    _
    Co-Authors (112)
    Explore
    _
    Similar People (60)
    Explore
    _